Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors

Details for Australian Patent Application No. 2005271275 (hide)

Owner Shire Holdings AG

Inventors Franklin, Richard

Agent Davies Collison Cave

Pub. Number AU-A-2005271275

PCT Pub. Number WO2006/017823

Priority 60/598,432 04.08.04 US

Filing date 4 August 2005

Wipo publication date 16 February 2006

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/017823 Priority application(s): WO2006/017823

3 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271281-System and method for virtual print devices for command implementation

2005271274-Quinazoline derivatives and their use in the treatment of thrombocythemia